| Product Code: ETC10765519 | Publication Date: Apr 2025 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In the Indonesia pemetrexed market, the import trend experienced a notable decline from 2023 to 2024, with a growth rate of -47.67%. The compound annual growth rate (CAGR) for the period 2020-2024 stood at -27.67%. This downward momentum in imports could be attributed to shifting demand dynamics or changes in trade policies impacting market stability.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Pemetrexed Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Pemetrexed Market Revenues & Volume, 2022 & 2032F |
3.3 Indonesia Pemetrexed Market - Industry Life Cycle |
3.4 Indonesia Pemetrexed Market - Porter's Five Forces |
3.5 Indonesia Pemetrexed Market Revenues & Volume Share, By Indication, 2022 & 2032F |
3.6 Indonesia Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2022 & 2032F |
3.7 Indonesia Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2022 & 2032F |
3.8 Indonesia Pemetrexed Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.9 Indonesia Pemetrexed Market Revenues & Volume Share, By Administration Route, 2022 & 2032F |
4 Indonesia Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lung cancer in Indonesia |
4.2.2 Growing awareness about the benefits of pemetrexed in cancer treatment |
4.2.3 Rising healthcare expenditure and improved access to advanced oncology treatments in the country |
4.3 Market Restraints |
4.3.1 High cost associated with pemetrexed treatment |
4.3.2 Limited availability of skilled healthcare professionals for administering pemetrexed |
4.3.3 Stringent regulatory requirements for importing and distributing pemetrexed in Indonesia |
5 Indonesia Pemetrexed Market Trends |
6 Indonesia Pemetrexed Market, By Types |
6.1 Indonesia Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Pemetrexed Market Revenues & Volume, By Indication, 2022 - 2032F |
6.1.3 Indonesia Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2022 - 2032F |
6.1.4 Indonesia Pemetrexed Market Revenues & Volume, By Mesothelioma, 2022 - 2032F |
6.1.5 Indonesia Pemetrexed Market Revenues & Volume, By Breast Cancer, 2022 - 2032F |
6.1.6 Indonesia Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2022 - 2032F |
6.1.7 Indonesia Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2022 - 2032F |
6.2 Indonesia Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Pemetrexed Market Revenues & Volume, By Antifolate, 2022 - 2032F |
6.2.3 Indonesia Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2022 - 2032F |
6.2.4 Indonesia Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2022 - 2032F |
6.2.5 Indonesia Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2022 - 2032F |
6.2.6 Indonesia Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2022 - 2032F |
6.3 Indonesia Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2022 - 2032F |
6.3.3 Indonesia Pemetrexed Market Revenues & Volume, By Immunotherapy, 2022 - 2032F |
6.3.4 Indonesia Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2022 - 2032F |
6.3.5 Indonesia Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2022 - 2032F |
6.3.6 Indonesia Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2022 - 2032F |
6.4 Indonesia Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Indonesia Pemetrexed Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Indonesia Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2022 - 2032F |
6.4.4 Indonesia Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2022 - 2032F |
6.4.5 Indonesia Pemetrexed Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
6.4.6 Indonesia Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2022 - 2032F |
6.5 Indonesia Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 Indonesia Pemetrexed Market Revenues & Volume, By Intravenous, 2022 - 2032F |
6.5.3 Indonesia Pemetrexed Market Revenues & Volume, By Injection, 2022 - 2032F |
6.5.4 Indonesia Pemetrexed Market Revenues & Volume, By IV Infusion, 2022 - 2032F |
6.5.5 Indonesia Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2022 - 2032F |
6.5.6 Indonesia Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2022 - 2032F |
7 Indonesia Pemetrexed Market Import-Export Trade Statistics |
7.1 Indonesia Pemetrexed Market Export to Major Countries |
7.2 Indonesia Pemetrexed Market Imports from Major Countries |
8 Indonesia Pemetrexed Market Key Performance Indicators |
8.1 Number of oncology clinics/hospitals offering pemetrexed treatment |
8.2 Patient adherence rate to pemetrexed therapy |
8.3 Number of ongoing clinical trials or research studies on pemetrexed efficacy and safety |
9 Indonesia Pemetrexed Market - Opportunity Assessment |
9.1 Indonesia Pemetrexed Market Opportunity Assessment, By Indication, 2022 & 2032F |
9.2 Indonesia Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2022 & 2032F |
9.3 Indonesia Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2022 & 2032F |
9.4 Indonesia Pemetrexed Market Opportunity Assessment, By End User, 2022 & 2032F |
9.5 Indonesia Pemetrexed Market Opportunity Assessment, By Administration Route, 2022 & 2032F |
10 Indonesia Pemetrexed Market - Competitive Landscape |
10.1 Indonesia Pemetrexed Market Revenue Share, By Companies, 2025 |
10.2 Indonesia Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here